Imaging genomics of cancer: a bibliometric analysis and review
Xinyi Gou,
Aobo Feng,
Caizhen Feng
и другие.
Cancer Imaging,
Год журнала:
2025,
Номер
25(1)
Опубликована: Март 4, 2025
Imaging
genomics
is
a
burgeoning
field
that
seeks
to
connections
between
medical
imaging
and
genomic
features.
It
has
been
widely
applied
explore
heterogeneity
predict
responsiveness
disease
progression
in
cancer.
This
review
aims
assess
current
applications
advancements
of
Literature
on
cancer
was
retrieved
selected
from
PubMed,
Web
Science,
Embase
before
July
2024.
Detail
information
articles,
such
as
systems
features,
were
extracted
analyzed.
Citation
Science
Scopus.
Additionally,
bibliometric
analysis
the
included
studies
conducted
using
Bibliometrix
R
package
VOSviewer.
A
total
370
articles
study.
The
annual
growth
rate
24.88%.
China
(133)
USA
(107)
most
productive
countries.
top
2
keywords
plus
"survival"
"classification".
research
mainly
focuses
central
nervous
system
(121)
genitourinary
(110,
including
44
breast
articles).
Despite
different
utilizing
modalities,
more
than
half
each
employed
radiomics
Publication
databases
provide
data
support
for
research.
development
artificial
intelligence
algorithms,
especially
feature
extraction
model
construction,
significantly
advanced
this
field.
conducive
enhancing
related-models'
interpretability.
Nonetheless,
challenges
sample
size
standardization
construction
must
overcome.
And
trends
revealed
study
will
guide
future
contribute
accurate
diagnosis
treatment
clinic.
Язык: Английский
The diagnostic value of a breast cancer diagnosis model based on serum MiRNAs and serum tumor markers
World Journal of Surgical Oncology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 29, 2025
Abstract
Background
Breast
cancer
(BCa)
is
the
leading
cause
of
cancer-related
death
among
women
worldwide.
MicroRNAs
(miRNAs)
are
promising
tools
for
diagnosis
and
prognosis.
This
study
investigated
role
serum
miRNAs
tumor
markers
(TMs)
in
BCa.
Methods
Differentially
expressed
were
screened
from
samples
BCa
patients
healthy
individuals
via
high-throughput
sequencing.
The
expression
hsa-miR-1911-3p,
hsa-miR-4694-5p,
hsa-miR-548ao-5p,
hsa-miR-4804-3p
169
116
controls
was
detected
qRT-PCR.
Serum
tumor-associated
antigens
by
chemiluminescence.
Logistic
regression
subsequently
used
to
develop
miRNA
panel
I,
TM
II,
(miRNA
+
TM)
III
models.
Receiver
operating
characteristic
(ROC)
curve,
precision-recall
(PR)
curve
decision
analyses
(DCA)
performed
assess
accuracy
three
models
diagnosis.
Additionally,
relationships
between
clinical
characteristics
with
assessed.
Results
Four
(hsa-miR-1911-3p,
hsa-miR-4804-3p)
newly
associated
I
based
on
hsa-miR-548ao-5p
showed
greater
diagnostic
effectiveness
than
II
antigen
125
(CA125)
153
(CA153),
AUC
values
0.816
0.777,
respectively.
had
higher
an
value
0.870.
miR-548ao-5p
miR-4804-3p
closely
related
features,
such
as
human
epidermal
growth
factor
receptor
2
(HER2),
estrogen
(ER),
progesterone
(PR),
HER2-enriched
subtype,
stage
III/IV,
lymph
node-transplanted
breast
cancer.
Conclusion
MiR-548ao-5p
miR-4804-3
could
serve
potential
biomarkers
Язык: Английский
Case Report: Multidisciplinary discussion and management of a case involving a non-seminomatous germ cell tumor complicated by the presence of cancerous thrombus in the inferior vena cava
Frontiers in Oncology,
Год журнала:
2025,
Номер
15
Опубликована: Апрель 16, 2025
Testicular
cancer
predominantly
manifests
in
younger
males.
It
demonstrates
a
favorable
response
to
cisplatin-based
chemotherapy
and
exhibits
promising
overall
survival.
Nevertheless,
the
emergence
of
certain
rare
complications,
such
as
development
an
embolus
vena
cava
due
cancer,
suggests
that
tumor
high
degree
aggressiveness
is
associated
with
poorer
prognosis.
We
present
case
stage
IIIC
mixed
malignant
germinoma
metastases
both
lungs,
left
kidney,
right
paravascular
iliac
lymph
nodes,
periaortic
inferior
thrombus.
Following
Multi-disciplinary
Team
(MDT)
discussion,
treatment
modalities
including
surgery
adjuvant
were
devised,
resulting
optimal
therapeutic
outcomes
without
complications
or
significant
adverse
reactions.
Язык: Английский